131I-iodometomidate

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug Name131I-iodometomidate
Drug Alias Name131I-IMTOiodine-131-iodometomidate
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSteroid 11-beta-hydroxylase inhibitorsCytochrome P450 11B2 inhibitors
TargetsCytochrome P450 11B2Steroid 11-beta-hydroxylase
Therapy Area/IndicationsAdrenocortical Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Wurzburg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Wurzburg
Active IndicationsN/A
Inactive IndicationsAdrenocortical Carcinoma

Other Information

ATC CodeN/A
Related LinksN/A